The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Ratings of L‐DOPA‐Induced Dyskinesia in the Unilateral 6‐OHDA Lesion Model of Parkinson's Disease in Rats and Mice
Abstract
This unit provides detailed protocols for establishing rodent models of L‐DOPA‐induced dyskinesia. The 6‐hydroxydopamine (6‐OHDA) lesion procedure is described in more detail for mice than for rats since the lesioning procedure in rats has been described extensively in previous work and is less difficult to perform. Unlike primate models, rodent models of L‐DOPA‐induced dyskinesia are relatively simple and fast to set up, thus being affordable to most laboratories. These models allow for studying the dyskinetic complications of L‐DOPA treatment on large groups of animals under strictly controlled experimental conditions. Along with information and structured protocols for the practical execution of the test, this unit provides a detailed description of the rating scale and the phenomenology of rodent abnormal involuntary movements, and suggestions for beginners. Curr. Protoc. Neurosci. 41:9.25.1‐9.25.23. © 2007 by John Wiley & Sons, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
6-hydroxy-dopamine induced degeneration of central monoamine neurons
Ungerstedt, U. (1968) · European Journal of Pharmacology · doi:10.1016/0014-2999(68)90164-7 · Cited by 1,460
Ahlskog, J. E., & Muenter, M. D. (2001) · Movement Disorders · doi:10.1002/mds.1090 · Cited by 1,454
Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L., & Bland, S. T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00005-8 · Cited by 1,354
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
Sauer, H., & Oertel, W. H. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90605-x · Cited by 803
Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Self-citationCenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00285.x · Cited by 641
Self-citationAnimal models of neurological deficits: how relevant is the rat?
Cenci, M. A., Whishaw, I. Q., & Schallert, T. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn877 · Cited by 456
Self-citationWinkler, C., Kirik, D., Björklund, A., & Cenci, M. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0499 · Cited by 430
Self-citationBehavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
Iancu, R., Mohapel, P., Brundin, P., & Paul, G. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.023 · Cited by 376
Andersson, M., Hilbertson, A., & Cenci, M. A. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0259 · Cited by 350
Self-citationLundblad, M., Picconi, B., Lindgren, H., & Cenci, M. A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.007 · Cited by 330
Self-citationDopamine dysregulation of movement control in l-DOPA-induced dyskinesia
Cenci, M. A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.005 · Cited by 265
Self-citationDekundy, A., Lundblad, M., Danysz, W., & Cenci, M. A. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.013 · Cited by 219
Self-citationPost‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesia
Cenci, M. A., & Lundblad, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04124.x · Cited by 218
Self-citationLee, C. S. (2000) · Brain · doi:10.1093/brain/123.7.1365 · Cited by 212
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia
Lundblad, M., Usiello, A., Carta, M., Håkansson, K., Fisone, G., & Cenci, M. A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.02.002 · Cited by 202
Self-citationDisease model: Parkinson's disease
Shimohama, S., Sawada, H., Kitamura, Y., & Taniguchi, T. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00117-5 · Cited by 190
Meissner, W. G., Ravenscroft, P., Reese, R., Harnack, D., Morgenstern, R., Kupsch, A. R., Klitgaard, H., Bioulac, B. H., Gross, C. E., Bézard, E., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.009 · Cited by 162
Schallert, T., & Tillerson, J. L. (2000) · Central Nervous System Diseases · doi:10.1007/978-1-59259-691-1_8 · Cited by 159
Role of striatal l ‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats
Carta, M., Lindgren, H. S., Lundblad, M., Stancampiano, R., Fadda, F., & Cenci, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03696.x · Cited by 157
Self-citationClinical–Pathological study of levodopa complications
Rajput, A. H., Fenton, M. E., Birdi, S., Macaulay, R. J. B., George, D. H., Rozdilsky, B., Ang, L. C., Senthilselvan, A., & Hornykiewicz, O. (2002) · Movement Disorders · doi:10.1002/mds.10031 · Cited by 136
Westin, J. E., Andersson, M., Lundblad, M., & Cenci, M. A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01743.x · Cited by 129
Self-citationEffect of Long-term Therapy on the Pharmacodynamics of Levodopa
Nutt, J. G. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530350037016 · Cited by 127
Spontaneous Regeneration of Nigrostriatal Dopaminergic Neurons in MPTP-Treated C57BL/6 Mice
Mitsumoto, Y., Watanabe, A., Mori, A., & Koga, N. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8986 · Cited by 114
Lindgren, H. S., Ottosson, D. R., Ohlin, K. E., Lundblad, M., & Cenci, M. A. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.09.019 · Cited by 111
Self-citationRousselet, E., Joubert, C., Callebert, J., Parain, K., Tremblay, L., Orieux, G., Launay, J., Cohen‐Salmon, C., & Hirsch, É. C. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00108-6 · Cited by 98
Cenci, M. A., Campbell, K., & Björklund, A. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90062-k · Cited by 82
Self-citationMDMA and fenfluramine reduce L‐DOPA‐induced dyskinesia via indirect 5‐HT1A receptor stimulation
Bishop, C., Taylor, J. L., Kuhn, D. M., Jaunarajs, K. L. E., Park, J. Y., & Walker, P. D. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04790.x · Cited by 63
Steiner, H., & Kitai, S. T. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01756.x · Cited by 59
Shen, H., Kannari, K., Yamato, H., Arai, A., & Matsunaga, M. (2003) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.199.149 · Cited by 48
Pinna, A., Pontis, S., & Morelli, M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.021 · Cited by 40
Cenci, M. A., & Lundblad, M. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50016-5 · Cited by 37
Self-citationMazzella, L., Yahr, M. D., Marinelli, L., Huang, N., Moshier, E. L., & Rocco, A. D. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.002 · Cited by 30
Stefanova, N., Lundblad, M., Tison, F., Poewe, W. H., Cenci, M. A., & Wenning, G. K. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.025 · Cited by 27
Self-citation
Cited by
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Diametric neural ensemble dynamics in parkinsonian and dyskinetic states
Parker, J. G., Marshall, J. D., Ahanonu, B., Wu, Y.-W., Kim, T. H., Grewe, B. F., Zhang, Y., Li, J. Z., Ding, J. B., Ehlers, M. D., et al. (2018) · Nature · doi:10.1038/s41586-018-0090-6 · Cited by 349
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
Fieblinger, T., Graves, S. M., Sebel, L. E., Alcacer, C., Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Cenci, M. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6316 · Cited by 295
Self-citationLindgren, H. S., Andersson, D. R., Lagerkvist, S., Nissbrandt, H., & Cenci, M. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06556.x · Cited by 263
Self-citation
Metadata
- Authors
- Cenci, M. A., & Lundblad, M.
- Venue
- Current Protocols in Neuroscience
- Publisher
- Wiley
- Published
- 2007-10
- Volume
- 41
- Issue
- 1
- Pages
- Unit 9.25-Unit 9.25
- ISSN
- 1934-8576 (ISSN-L)
- 1934-8584
- OpenAlex
- W1756893006
- Cited by
- 266
- References
- 37
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.